LGNDNasdaq

LIGAND PHARMACEUTICALS INC

Pharmaceutical Preparations · DE · CIK 886163

Ligand Pharmaceuticals develops and acquires royalty-dependent biotechnology and pharmaceutical assets

red 8-K · 90d

$6.40B

Market cap

$319.55

Last close

+2.4%

+8.0%

368K

Volume

Price$319.55+181.1%· 1Y

Jul 2L $113.66 · H $319.55Jul 2

298

Total filings

Jun 25, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance

Date	Insider	Action	Shares	Price	Value
Mar 23, 2026	Sabba Stephen LDirector	Sell	1,000	$207.87	$208K
Mar 11, 2026	Espinoza OctavioChief Financial Officer	Sell	3,057	$225.00	$688K
Mar 6, 2026	Lamattina John LDirector	Sell	2,161	$200.76	$434K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	3,413	$208.80	$713K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	2,457	$207.91	$511K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	1,588	$206.89	$329K
Mar 4, 2026	Reardon AndrewCLO & Secretary	Sell	1,446	$208.12	$301K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	1,457	$205.79	$300K
Mar 4, 2026	Reardon AndrewCLO & Secretary	Sell	1,142	$208.87	$239K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	950	$201.73	$192K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	743	$204.74	$152K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	697	$202.79	$141K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	698	$201.09	$140K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	699	$198.71	$139K
Mar 4, 2026	Espinoza OctavioChief Financial Officer	Sell	668	$203.63	$136K
Mar 4, 2026	Reardon AndrewCLO & Secretary	Sell	612	$207.01	$127K
Mar 4, 2026	Reardon AndrewCLO & Secretary	Sell	460	$205.18	$94K
Mar 4, 2026	Reardon AndrewCLO & Secretary	Sell	340	$206.37	$70K
Mar 4, 2026	Reardon AndrewCLO & Secretary	Sell	300	$201.70	$61K
Mar 4, 2026	Reardon AndrewCLO & Secretary	Sell	207	$199.96	$41K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.